Nasus Pharma Ltd. (NSRX)
NYSEAMERICAN: NSRX · Real-Time Price · USD
3.320
+0.020 (0.61%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Nasus Pharma Employees
Nasus Pharma had 7 employees as of December 31, 2025. The number of employees increased by 5 or 250.00% compared to the previous year.
Employees
7
Change (1Y)
5
Growth (1Y)
250.00%
Revenue / Employee
n/a
Profits / Employee
-$836,571
Market Cap
38.88M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | 5 | 250.00% | 7 | 0 |
| Dec 31, 2024 | 2 | - | - | 1 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Pfizer | 75,000 |
| Sanofi | 74,846 |
| GSK plc | 66,841 |
| Bristol-Myers Squibb Company | 32,500 |
| Grifols | 25,247 |
| Organon & Co. | 10,000 |
| Biogen | 7,500 |
| Amarin Corporation | 80 |
NSRX News
- 4 days ago - Nasus Pharma Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 6 days ago - Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum - GlobeNewsWire
- 18 days ago - Nasus Pharma Transcript: KOL event - Transcripts
- 19 days ago - Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003) - GlobeNewsWire
- 20 days ago - Nasus Pharma Slides: Company presentation - Filings
- 27 days ago - Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis - GlobeNewsWire
- 2 months ago - Nasus Pharma to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Nasus Pharma Transcript: Biotech Resurgence: Platforms and Pipelines of Today's Innovators - Transcripts